Proposal for a Regulation of the European Parliament and of the Council on drug precursors
Date: 2002-09-10
Institutions: European Commission
Subjects: administrative cooperation, chemical product, customs document, customs harmonisation, customs inspection, dissemination of information, drug traffic, international trade, psychotropic substance

C 20 E/160

EN

Official Journal of the European Communities

28.1.2003

Proposal for a Regulation of the European Parliament and of the Council on drug precursors

(2003/C 20 E/15)

(Text with EEA relevance)

COM(2002) 494 final — 2002/0217(COD)

(Submitted by the Commission on 10 September 2002)

EXPLANATORY MEMORANDUM

1. Introduction

An effective control of the chemicals used in the illegal production of narcotic drugs and psychotropic
substances has proved to be one of the most efficient weapons against drug trafficking. As is very often
said: there are no drugs without precursors. However, in the majority of cases, precursors are chemical
products that also have legal and legitimate uses. Legitimate trade of these substances should therefore be
recognised and protected.

In this context, the European Community has adopted two legal instruments laying down the measures to
be taken to discourage the diversion of certain substances to the illicit manufacture of narcotic drugs and
psychotropic substances. Council Regulation (EEC) No 3677/90 (1) aims at surveillance of the trade in
precursors between the Member States and third countries while Directive 92/109/EEC (2) does the same
regarding the internal market.

In January 1998 the Commission adopted a proposal for the amendment (3) of Directive 92/109/EEC,
hereinafter referred to as ‘the Directive’. In its first reading, Parliament supported the Commission initiative
and proposed five amendments (4). The Commission reacted to the Parliament's opinion (first reading) by
adopting an amended proposal (5). The Council has not yet taken any decision on the proposal.

2. Objectives of the Commission proposal

Article 12 of the 1988 United Nations Convention against Illicit Traffic in Narcotic Drugs and Psycho-
tropic Substances (Vienna Convention) provides for control measures for trade in twenty-three substances
which, while also having numerous licit uses, are frequently diverted for use in the clandestine manu-
facture of narcotic drugs and psychotropic substances. In accordance with the Convention, the manu-
facture and placing on the Community market of such substances are subject to strict surveillance, in
particular pursuant to Directive 92/109/EEC.

By transforming the current Directive into a Regulation the Commission aims mainly at simplifying the
legislation and thus making it more user-friendly. This becomes especially important in the context of the
on-going process of enlargement of the European Union where each modification of the Directive and its
annexes would have triggered national implementation measures in some twenty-five Member States.

(1) OJ L 357, 20.12.1990, p. 1, as last amended by Council Regulation (EC) No 1116/2001 (OJ L 153, 8.6.2001, p. 4).
(2) OJ L 370, 19.12.1992, p. 76.
(3) Document COM(1998) 22 final (OJ C 108, 7.4.1998, p. 41).
(4) Document PE 273.796/1.
(5) Document COM(1999) 202 final (OJ C 162, 9.6.1999, p. 9).

28.1.2003

EN

Official Journal of the European Communities

C 20 E/161

Furthermore, it should be stressed that the above-mentioned Regulation (EEC) No 3677/90 has the same
basic objectives as the Directive. Whereas the Regulation concerns the trade of substances between the
European Community and third countries, the Directive deals with drug precursors in the Internal Market.
This results in an uneven application of the two instruments because a modification of the Regulation's
annexes will be applicable simultaneously in all Member States within a few days from publication (1),
while the corresponding modification of the Directive's annexes is subject to a transposition period that
most Member States are unable to meet (2). In practice, delays of up to forty-two months have occurred in
the past before the modifying directives were fully transposed into national law. The result is that the
controls on newly identified drug precursors in the Internal Market lacked efficiency. A continuation of
this situation cannot be justified and a uniform application of Community law in this area is needed to
avoid any diversion of drug precursors into the production of illegal drugs.

The Commission has therefore decided to withdraw the proposal
for an amendment of Directive
92/109/EEC. The Regulation now proposed would better ensure that the provisions are directly applied
by economic operators and that harmonised measures are implemented in all Member States at the same
time. It would permit the legitimate use of the affected chemical substances to be monitored and would
avoid their diversion to the manufacture of illegal drugs. It will also ensure that the implementation of this
new instrument is as rapid as that of Regulation 3677/90.

3. Content of the Commission proposal

The aim of the new Regulation is to establish harmonised measures of control and monitoring of certain
chemical substances frequently used in the manufacture of illegal narcotic drugs. The new Regulation will
prevent barriers to the free trade of these substances between Member States. In order to achieve this aim,
the proposed Regulation contains rules on licensing, customer declarations, labelling and a monitoring
procedure.

In addition, the Commission proposes that the new Regulation should take account of the changeable
nature of the illicit manufacture of narcotic drugs and to align it with the already published amendments
to Regulation (EEC) No 3677/90.

A further improvement to the current situation will be to oblige the Member States to distribute to
economic operators information on how to recognise and notify suspect transactions so that economic
operators inform the competent authorities of suspect transactions involving substances not currently
mentioned in the Directive but which are nevertheless frequently used to manufacture synthetic drugs.
This co-operative approach has already been tried and tested in a number of Member States (France,
Germany, Austria, United Kingdom, The Netherlands). The Commission, assisted by the Committee
referred to in Article 15 of the new Regulation, will be responsible for drawing up and constantly
updating the lists of products which are to be subject to such surveillance. These lists will be distributed
to economic operators by the Member States.

The Commission takes this opportunity to define more clearly what it means by a ‘scheduled substance’,
since the measures applicable to Sassafras Oil are currently interpreted in different ways in the Community.
In some Member States it is regarded as a mixture containing Safrole, and is therefore controlled, while
other Member States regard it as a natural product not subject to controls. Inserting a reference to natural
products in the definition of ‘scheduled substance’ resolves this discrepancy and therefore allows controls
to be applied to Sassafras Oil; only natural products from which scheduled substances can be easily
extracted are covered by the definition.

(1) See Commission Regulation (EC) No 260/2001 (OJ L 39, 9.2.2001, p. 11) which entered into force nineteen days

after the publication in the Official Journal, on 1 March 2001.

(2) See Commission Directive 2001/8/EC (OJ L 39, 9.2.2001, p. 31) whose transposition has not yet been completed in

all Member States.

C 20 E/162

EN

Official Journal of the European Communities

28.1.2003

The Commission also proposes to define ‘non-scheduled substances’ in conformity with Article 12(12)(b)
of the United Nations Convention.

As a final point, the Commission considers this a good opportunity to take into account the revision of the
classification for Potassium Permanganate. The Committee referred to in Article 15 of the new Regulation,
has considered that this chemical gives rise to particular concern. The Committee has recommended the
classification of Potassium Permanganate in category 2 of Annex I. Thresholds have been set up for
Potassium Permanganate as well as for Acetic Anhydride to ensure that internal trade of these products
will not be negatively affected.

THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE
EUROPEAN UNION,

Having regard to the Treaty establishing the European
Community, and in particular Article 95 thereof,

Having regard to the proposal from the Commission,

Having regard to the opinion of the Economic and Social
Committee,

Acting in accordance with the procedure laid down in Article
251 of the Treaty,

Whereas:

facture and distribution of precursors. This requires the
adoption of measures relating to the trade of precursors
among Member States. Such measures were introduced by
Council Directive 92/109/EEC of 14 December 1992 on
the manufacture and placing on the market of certain
substances used in the illicit manufacture of narcotic
drugs and psychotropic substances. To better ensure
that harmonised rules are applied at the same time in
all Member States a Regulation is deemed to be more
adequate than the current Directive.

(4) By decisions taken at its thirty-fifth session, 1992, the
United Nations Commission on Narcotic Drugs included
additional substances in the tables of the Annex to the
Convention. Corresponding provisions should be laid
to detect possible
down in this Regulation in order
cases of illicit diversion of drugs in the Community and
to ensure that common monitoring rules are applied in
the Community market.

(1) The United Nations Convention against Illicit Traffic in
Narcotic Drugs and Psychotropic Substances, adopted in
Vienna on 19 December 1988, hereinafter referred to as
the ‘United Nations Convention’, was approved by the
Community, with
its
90/611/EEC of
competence,
22 October 1990 (1).

respect
by Council Decision

to matters within

in respect of

trade in precursors,

(2) The requirements of Article 12 of the United Nations
(i.e.
Convention,
substances frequently used in the illicit manufacture of
narcotic drugs or psychotropic substances), are imple-
mented as far as trade between the Community and
third countries
concerned by Regulation (EEC)
No 3677/90 of 13 December 1990 laying down
measures to be taken to discourage the diversion of
certain substances to the illicit manufacture of narcotic
drugs and psychotropic substances (2).

is

(3) Article 12 of the United Nations Convention envisages
adoption of appropriate measures to monitor manu-

(1) OJ L 326, 24.11.1990, p. 56, Council Decision 90/611/EEC of
22 October 1990 concerning the conclusion, on behalf of the
European Economic Community, of the United Nations Convention
against Illicit Traffic in Narcotic Drugs and Psychotropic Substances.
(2) OJ L 357, 20.12.1990, p. 1, as last amended by Council Regulation

(EC) No 1116/2001 (OJ L 153, 8.6.2001, p. 4).

(5) The provisions of Article 12 of

in question. Most

the United Nations
Convention are based on a system of monitoring trade
in the substances
trade in these
substances
is entirely lawful. The documentation of
consignments and labelling of these substances must be
It is furthermore important, whilst
sufficiently explicit.
authorities with the necessary
providing competent
means of action,
the
United Nations Convention mechanisms based on close
co-operation with the operators concerned and on the
development of intelligence gathering.

to develop within the spirit of

(6) The measures applicable to Sassafras Oil are currently
interpreted in different ways in the Community, since it
is
regarded as a mixture containing Safrole and is
therefore controlled in some Member States, while other
Member States regard it as a natural product not subject
to controls. Inserting a reference to natural products in
the definition of
this
discrepancy and therefore allows controls to be applied
to Sassafras Oil; only natural products
from which
scheduled substances can be easily extracted are covered
by the definition.

‘scheduled substance’

resolves

28.1.2003

EN

Official Journal of the European Communities

C 20 E/163

(7) Substances commonly used in the illicit manufacture of
narcotic drugs and psychotropic substances should be
listed in an Annex.

lation, may be used in the illicit manufacture of synthetic
drugs, guidelines should be drawn up aimed at helping
this industry.

(8) It should be ensured that

the manufacture or use of
certain scheduled substances
listed in the Annex is
subject to possession of a licence. The supply of such
substances should in addition be permitted only where
the persons to whom they are to be supplied are either
holders of
customer
declaration. The detailed rules concerning the customer
declaration should be laid down in Annex III.

licence or have

signed a

a

(9) Measures should be adopted to encourage operators to
notify suspicious transactions involving substances listed
in Annex I to the competent authorities.

(10) Measures should be adopted in order to guarantee better
control of intra-community trade of scheduled substances
listed in Annex I.

(11) All transactions leading to the placing on the market of
scheduled substances in categories 1 and 2 of Annex I
should be properly documented. Operators shall notify
the Competent Authorities of any suspect transactions
involving the substances listed in Annex I. However,
exemptions
should apply to transactions concerning
substances in category 2 of Annex I where the quantities
involved do not exceed those indicated in Annex II.

(12) A significant number of other substances, many of them
traded legally in large quantities, have been identified as
precursors to the illicit manufacture of synthetic drugs. To
subject these substances to the same strict controls as
those listed in the Annex would present an unnecessary
obstacle to trade involving licences to operate and docu-
transactions. Therefore, a more flexible
mentation of
mechanism at Community level should be established
whereby the competent authorities in the Member States
are notified of such transactions.

(13) The introduction of a cooperation procedure is provided
for in the European Union Action Plan against drugs
approved by the European Council of Santa Maria da
Feira on 19 and 20 June 2000.
In order to support
co-operation between the Member State administrations
and the chemicals industry,
in particularly with regard
to substances which, though not referred to in this regu-

(14) The measures necessary for the implementation of this
Regulation should be
adopted in accordance with
Council Decision 1999/468/EC of 28 June 1999 laying
down the procedures for the exercise of implementing
powers conferred on the Commission (1).

(15) Since

the objectives of

the proposed action,

the
harmonised monitoring of the trade in drug precursors
and the avoidance of its diversion to the illegal production
of narcotic drugs, cannot be sufficiently achieved by the
Member States, and can therefore, by reason of its inter-
national and changeable nature, be better achieved at
Community level, the Community may adopt measures,
in accordance with the principle of subsidiarity as set out
in Article 5 of
In accordance with the
principle of proportionality, as set out in that Article,
this Regulation does not go beyond what is necessary in
order to achieve those objectives.

the Treaty.

(16) Council Directive 92/109/EEC of 14 December 1992 (2),
Commission Directives 93/46/EEC of 22 June 1993 (3)
and 2001/8/EC of 8 February 2001 (4), and Commission
Regulations (EC) No 1485/96 of 26 July 1996 (5) and (EC)
No 1533/2000 of 13 July 2000 (6) should be repealed,

HAVE ADOPTED THIS REGULATION:

Article 1

Scope and objectives

the
This Regulation establishes harmonised measures
control and monitoring of certain substances frequently used
for the illicit manufacture of narcotic drugs and psychotropic
substances with a view to preventing the diversion of such
substances.

for

(1) OJ L 184, 17.7.1999, p. 23.
(2) OJ L 370, 19.12.1992, p. 76, Council Directive 92/109/EEC of
14 December 1992 on the manufacture and the placing on the
market of certain substances used in the illicit manufacture of
narcotic drugs and psychotropic substances.

(3) OJ L 159, 1.7.1993, p. 134, Directive 93/46/EEC of 22 June 1993
replacing and modifying the Annexes
to Council Directive
92/109/EEC on the manufacture and placing on the market of
certain substances used in the illicit manufacture of narcotic
drugs and psychotropic substances.

(4) OJ L 39, 9.2.2001, p. 31, Directive 2001/8/EC of 8 February 2001
replacing Annex I to Council Directive 92/109/EEC on the manu-
facture and placing on the market of certain substances used in the
illicit manufacture of narcotic drugs and psychotropic substances.
(5) OJ L 188, 27.7.1996, p. 28, Regulation (EC) No 1485/96 of 26 July
1996 laying down detailed rules for the application of Council
Directive 92/109/EEC, as regards customer declarations of specific
use relating to certain substances used in the illicit manufacture of
narcotic drugs and psychotropic substances.

(6) OJ L 175, 14.7.2000, p. 75, Commission Regulation (EC)
No 1533/2000 of 13 July 2000 amending Regulation (EC)
No 1485/96 laying down detailed rules for the application of
Council Directive 92/109/EEC, as regards customer declarations of
specific use relating to certain substances used in the illicit manu-
facture of narcotic drugs and psychotropic substances.

C 20 E/164

EN

Official Journal of the European Communities

28.1.2003

Article 2

Definitions

For the purposes of this Regulation the following definitions
shall apply:

(a) scheduled substance means any substance listed in Annex I,
including mixtures and natural products containing such
substances. This excludes medicinal products (as defined
by Directive 2001/83/EC (1)), pharmaceutical preparations,
mixtures,
preparations
containing scheduled substances that are compounded in
such a way that such substances cannot be easily used or
extracted by readily applicable or economically viable
means;

products

natural

other

and

(b) non scheduled substance means any substance not included
in Annex I but which is identified as having been used in
illicit manufacture of narcotic drugs or psychotropic
substances;

(c) placing on the market means any supply, whether in return
of payment or free of charge, of scheduled substances; or
the storage, manufacture, production, trade, distribution or
brokering of these substances for the purpose of supply;

(d) operator means any natural or legal person engaged in the
placing on the market of scheduled substances in the
Community;

(e)

International Narcotics Control Board means the Board
established by the Single Convention on Narcotic Drugs,
1961, as amended by the 1972 Protocol.

Article 3

Article 4

Customer declaration and authorization

1.
Any operator established within the Community who
supplies a customer with a scheduled substance in categories
1 or 2 of Annex I to this Regulation shall obtain a declaration
from the customer which shows the specific use or uses of the
scheduled substances. A separate declaration shall be required
for each scheduled substance. This declaration shall conform to
the model set out in point 1 of Annex III to this Regulation. In
the case of legal persons, the declaration shall be made on
headed notepaper.

As an alternative to the above declaration for an indi-
2.
vidual
transaction, an operator who regularly supplies a
customer with a scheduled substance in category 2 of Annex
I to this Regulation may accept a single declaration in respect
transactions over a period of one year
of a number of
maximum provided that
satisfied the
following criteria have been met:

the operator

is

(a) the customer is one to whom he has supplied the substance
on at least three occasions in the preceding twelve months;

(b) the operator has no reason to suppose that the substance

will be used for illicit purposes;

(c)

the quantities ordered are consistent with the usual
consumption for that customer.

This declaration shall conform to the model set out in point 2
of Annex III to this Regulation. In the case of legal persons, the
declaration shall be made on headed notepaper.

Requirements for the manufacture and placing on the
market of scheduled substances

1.
Operators shall possess a licence issued by the competent
authorities before they place on the market in the Community
scheduled substances in category 1 of Annex I.

Any operator holding the licence referred to in Article 3
3.
shall supply scheduled substances specified in category 1 of
Annex I only to persons holding a licence in the sense of
Article 3 or having signed a customer declaration in the
sense of paragraphs 1 and 2 above.

2.
In considering whether to grant a licence, the competent
authorities shall take into account in particular the competence
and integrity of the applicant. The licence may be suspended or
revoked by the competent authorities whenever
there are
reasonable grounds for belief that the holder is no longer a
fit and proper person to hold a licence, or that the conditions
under which the licence was issued are no longer fulfilled.

3.
Operators engaged in the placing on the market of
scheduled substances in category 2 of Annex I shall be
required to register and update with the competent authorities
the addresses of the premises from which they manufacture or
trade in these substances.

(1) OJ L 311, 28.11.2001, p. 67.

thereby certifying that

4.
An operator supplying substances specified in category 1
of Annex I shall stamp and date a copy of the customer
to the
declaration,
original. This document must always accompany category 1
substances being moved within the Community and must be
presented on request to the authorities responsible for checking
vehicle contents during transport operations.

it corresponds

Article 5

Documentation

1.
Operators shall ensure that all transactions leading to the
placing on the market of scheduled substances in categories 1
and 2 of Annex I are properly documented in accordance with
paragraphs 2 to 5.

28.1.2003

EN

Official Journal of the European Communities

C 20 E/165

Commercial documents such as invoices, cargo manifests,
shipping
transport
information to identify

2.
administrative documents,
documents shall contain sufficient
positively:

and other

(a) the name of the scheduled substance as given in categories

1 and 2 of Annex I;

(b) the quantity and weight of the scheduled substance and,
where a mixture is concerned, the quantity and weight, if
available, of the mixture as well as the quantity and weight,
or
the percentage by weight, of any substance or
substances specified in categories 1 and 2 of Annex I
which are contained in the mixture;

(c) the name and address of the supplier, distributor and of the

consignee.

The documentation must furthermore contain a customer

3.
declaration as referred to in Article 4.

4.
Operators shall keep detailed records of their activities as
are required to comply with their obligations under paragraph
1.

5.
The documentation and records referred to in paragraphs
1 to 4 above shall be kept for a period of not less than three
years from the end of the calendar year in which the trans-
action referred to in paragraph 1 took place, and must be
readily available for inspection by the competent authorities
upon request.

Article 6

Exemptions

The obligations under Articles 3, 4 and 5 shall not apply to
transactions concerning scheduled substances in category 2 of
Annex I where the quantities involved do not exceed those
indicated in Annex II.

Article 7

Labelling

Operators shall provide the competent authorities in
2.
summary form with such information about their transactions
involving scheduled substances as the competent authorities
may require.

Article 9

Guidelines

industry,

in particular as

the Member States,

In order to facilitate cooperation between the competent
1.
the operators, and the
authorities of
chemical
regards non-scheduled
substances commonly used in the illicit manufacture of
narcotic drugs or psychotropic substances, the Commission
shall, in accordance with the procedure referred to in Article
15(2), draw up and update guidelines to assist the chemical
industry.

2.

The guidelines shall provide in particular:

(a)

information on how to recognise and notify suspect trans-
actions;

(b) a regularly updated list of non-scheduled substances
commonly used in the illicit manufacture of narcotic
drugs and psychotropic substances to enable industry to
monitor on a voluntary basis the trade in such substances;

(c) other information which may be deemed useful.

The competent authorities shall ensure that the guidelines
3.
and the list
referred to in paragraph 2(b) are regularly
disseminated in a manner deemed appropriate by the
competent authorities in accordance with the objectives of
the guidelines.

Article 10

Powers and obligations of Competent Authorities

In order to ensure the correct application of Articles 3 to 7,
each Member State shall adopt,
the measures necessary to
enable the competent authorities:

Operators shall ensure that
labels are affixed to scheduled
substances in categories 1 and 2 of Annex I before they are
placed on the market. Such labels must show the names of the
substances as given in Annex I. Operators may in addition affix
their customary labels.

(a) to obtain information on any orders

for

scheduled

substances or operations involving scheduled substances;

(b) to enter operators' business premises in order to obtain

evidence of irregularities;

Article 8

(c)

to respect confidential business information.

Notification of

the Competent Authorities
scheduled substances

regarding

Article 11

the

shall

notify

Operators

competent

authorities
1.
immediately of any circumstances, such as unusual orders or
transactions involving scheduled substances, which suggest that
such substances to be placed on the market or manufactured,
as the case may be, may be diverted for the illicit manufacture
of narcotic drugs or psychotropic substances.

Cooperation between the Member States

and the

Commission

Each Member State

1.
competent
authority or authorities responsible for ensuring the application
of this Regulation and inform the Commission thereof.

shall designate

the

C 20 E/166

EN

Official Journal of the European Communities

28.1.2003

3. The amendments to the thresholds set in Annex II.

4. The customer declaration form referred to in points 1 and 2
of Article 4, as well as the detailed rules concerning its use.

Article 15

Committee

The Commission shall be assisted by the committee set

1.
up by Article 10 of Regulation (EEC) No 3677/90.

2. Where reference is made to this paragraph Articles 4 and
7 of Decision 1999/468/EC shall apply, having regard to the
provisions of Article 8 thereof. The period referred to in Article
4(3) of Decision 1999/468/CE shall be three months.

3.

The Committee shall adopt its rules of procedure.

Article 16

Information about measures taken by Member States

Each Member State shall
measures it takes pursuant to this Regulation.

inform the Commission of

the

The Commission shall communicate this information to the
other Member States.

Article 17

Repeal

1.
Council Directive 92/109/EEC, Commission Directives
93/46/EEC and 2001/8/EC, and Commission Regulations (EC)
No 1485/96 and (EC) No 1533/2000 are hereby repealed.

References to the repealed Directives or Regulations shall

2.
be construed as references to the present Regulation.

3.
The validity of any licenses granted and any customer
declarations issued under the above Directives or Regulations
shall not be affected by the fact that these are replaced by the
present Regulation.

Article 18

Entry into force

This Regulation shall enter into force on the twentieth day
following that of its publication in the Official Journal of the
European Communities.

This Regulation shall be binding in its entirety and directly
applicable in all Member States.

For the purposes of applying this Regulation and without
2.
prejudice to Article 15, the provisions of Council Regulation
(EEC) No 515/97 (1), and in particular those on confidentiality
shall
authorities
designated under point 1 shall act as competent authorities
within the meaning of Article 2(2) of Regulation (EEC)
No 515/97.

apply mutatis mutandis. The

competent

Article 12

Penalties

The Member State shall
lay down the rules on penalties
applicable for infringement of the provisions of this Regulation
and shall take all measures necessary to ensure that they are
implemented. The penalties provided for must be sufficient,
proportionate and dissuasive. The Member States shall notify
those provisions to the Commission by [eighteen months] at
the latest and shall notify it without delay of any subsequent
amendment affecting them.

Article 13

Communications from Member States

competent authorities

To permit any necessary adjustments to the arrangements
1.
in scheduled substances and non
for monitoring trade
scheduled substances,
in each
the
Member State shall each year communicate to the Commission
all relevant information on the implementation of the moni-
toring measures laid down in this Regulation, in particular as
regards substances used for the illicit manufacture of narcotic
drugs or psychotropic substances and methods of diversion and
illicit manufacture.

2.
A summary of the communications made pursuant to
paragraph 1, in accordance with Article 12(12) of the United
Nations Convention and in consultation with the Member
States, shall be submitted by the Commission's services to
the International Narcotics Control Board.

Article 14

Implementation procedure

The following measures necessary for the implementation of
this Regulation shall be adopted in accordance with the
procedure referred to in Article 15(2).

1. The determination whenever necessary of the conditions
which shall apply to the documentation and labelling of
mixtures and preparations containing substances listed in
category 2 of Annex I, as provided for in Articles 5 and 6.

2. The amendment to the Annexes of the present Regulation,
in the event that the tables in the Annex to the United
Nations Convention should themselves be amended.

(1) OJ L 82, 22.3.1997, p. 1.

28.1.2003

EN

Official Journal of the European Communities

C 20 E/167

ANNEX I

Category 1

Substance

CN designation (if different)

CN code (*)

CAS No

1-Phenyl-2-propanone

Phenylacetone

2914 31 00

103-79-7

N-acetylanthranilic acid

2-Acetamidobenzoic acid

2924 23 00

89-52-1

Isosafrol (cis + trans)

2932 91 00

120-58-1

3,4-Methylenedioxyphenylpropane-2-one 1-(1,3-Benzodioxol-5-yl)propan-2-one

2932 92 00

4676-39-5

Piperonal

Safrole

Ephedrine

Pseudoephedrine

Norephedrine

Ergometrine

Ergotamine

Lysergic acid

2932 93 00

120-57-0

2932 94 00

94-59-7

2939 41 00

299-42-3

2939 42 00

90-82-4

2939 49 00

154-41-6

2939 61 00

60-79-7

2939 62 00

113-15-5

2939 63 00

82-58-6

(*) OJ L 278, 28.10.1999, p. 1.
The salts of the substances listed in this category whenever the existence of such salts is possible.

Category 2

Substance

CN designation (if different)

CN code (*)

CAS No

Acetic anhydride

Phenylacetic acid

Anthranilic acid

Piperidine

Potassium permanganate

2915 24 00

108-24-7

2916 34 00

103-82-2

2922 43 00

118-92-3

2933 32 00

110-89-4

2841 61 00

7722-64-7

(*) OJ L 278, 28.10.1999, p. 1.
The salts of the substances listed in this category whenever the existence of such salts is possible.

Category 3

Substance

CN designation (if different)

CN code (*)

CAS No

Hydrochloric acid

Hydrogen chloride

2806 10 00

7647-01-0

Sulphuric acid

Toluene (**)

Ethyl ether (**)

Acetone (**)

Diethyl ether

Methylethylketone (**)

Butanone

(*) OJ L 278, 28.10.1999, p. 1.
(**) The salts of these substances whenever the existence of such salts is possible.

2807 00 10

7664-93-9

2902 30 00

108-88-3

2909 11 00

60-29-7

2914 11 00

67-64-1

2914 12 00

78-93-3

C 20 E/168

EN

Official Journal of the European Communities

28.1.2003

Substance

Acetic anhydride

Potassium Permanganate

Anthranilic acid and its salts

Phenylacetic acid and its salts

Piperidine and its salts

ANNEX II

Threshold

100 l

100 kg

1 kg

1 kg

0,5 kg

28.1.2003

EN

Official Journal of the European Communities

C 20 E/169

ANNEX III

C 20 E/170

EN

Official Journal of the European Communities

28.1.2003